MedTrace Logo

Reduction of Sperm DNA Fragmentation by Oral Ginger

NCT02032251 · Status: COMPLETED · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 71

Last updated 2014-01-09

No results posted yet for this study

Summary

This study is a randomized, double blind, controlled clinical trials assess the efficacy of the ginger oral treatment on sperm DNA fragmentation, sperm parameters and male hormones.

Conditions

Interventions

DRUG

oral administration of ginger

Oral administration of ginger in patients with infertility.

DRUG

Placebo

Sponsors & Collaborators

  • Royan Institute

    lead OTHER_GOV

Principal Investigators

  • Hamid Gourabi, PhD · Head of Royan Institute

  • Ali DaliriHampa, MD · Department of Andrology, Reproductive Biomedicine Center, Royan Institute for Reproductive Biomedicine

  • Eyed Jalil Hosseini, MD · Department of Andrology, Reproductive Biomedicine Center, Royan Institute for Reproductive Biomedicine

  • Hani Department of Andrology, Reproductive Biomedicine Center, Roya, MSc · Department of Andrology, Reproductive Biomedicine Center, Royan Institute for Reproductive Biomedicine

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
20 Years
Max Age
50 Years
Sex
MALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2009-12-31
Primary Completion
2010-09-30
Completion
2010-11-30

Countries

  • Iran

Study Locations

More Related Trials

Entities

Drugs
Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02032251 on ClinicalTrials.gov